Cytokinetics, Inc. (CYTK) Posts Q1 Loss of 27c/Share
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $80.36 -2.74%
EPS Growth %: -45.5%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
DBVT, FNGR, SFNC, More
EPS Growth %: -45.5%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
DBVT, FNGR, SFNC, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.27), $0.07 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $8 million versus the consensus estimate of $7.69 million.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon to cut 3,000 jobs as it shifts stores to franchises
- Truist cuts Lululemon to sell, sees structural headwinds and nearly 20% downside
- ManpowerGroup (MAN) Tops Q2 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
